XML 56 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL AND OTHER INTANGIBLE ASSETS

Changes in the carrying amount of goodwill follow:
(Dollars in millions)
Additives & Functional Products
 
Advanced Materials
 
Chemical Intermediates
 
Other
 
Total
Balance at December 31, 2017
$
2,459

 
$
1,289


$
769


$
10


$
4,527

Impairments recognized
(38
)
 

 

 

 
(38
)
Currency translation adjustments
(11
)
 
(6
)
 
(5
)
 

 
(22
)
Balance at December 31, 2018
2,410

 
1,283

 
764

 
10

 
4,467

Acquisitions
15

 

 

 

 
15

Impairments recognized
(45
)
 

 

 

 
(45
)
Currency translation adjustments
(3
)
 
(1
)
 
(2
)
 

 
(6
)
Balance at December 31, 2019
$
2,377

 
$
1,282

 
$
762

 
$
10

 
$
4,431



Eastman conducts testing of goodwill annually in the fourth quarter or more frequently when events and circumstances indicate an impairment may have occurred. A reporting unit's goodwill is considered to be impaired when the reporting unit's estimated fair value is less than its carrying value. The Company uses an income approach and applies a discounted cash flow model in testing the carrying value of goodwill for each reporting unit. Key assumptions and estimates used in the Company's 2019 goodwill impairment testing included projections of revenues and EBIT determined using the Company's annual multi-year strategic plan, the estimated WACC, and a projected long-term growth rate. As a result of the goodwill impairment testing performed during fourth quarter 2019, fair values were determined to exceed the carrying values for each reporting unit tested with the exception of crop protection (part of the Additives & Functional Products ("AFP") segment).

In fourth quarter 2019 and 2018, as a result of the annual impairment test of goodwill, the Company recognized goodwill impairments of $45 million and $38 million, respectively, in the crop protection reporting unit. The impairment in 2019 was primarily due to the impact of recent regulatory changes in the European Union on current period and forecasted revenue and EBIT and a decrease in the long-term growth rate for the reporting unit assumed in the goodwill impairment model. The impairment in 2018 was primarily due to the WACC applied to the impairment analysis and the estimated impact of future regulatory changes. The crop protection reporting unit's goodwill after the reduction for impairment was $190 million as of December 31, 2019.

As of December 31, 2019, the reported balance of goodwill included accumulated impairment losses of $106 million, $12 million, and $14 million in the AFP segment, Chemical Intermediates ("CI") segment, and other segments, respectively.
As of December 31, 2018, the reported balance of goodwill included accumulated impairment losses of $61 million, $12 million, and $14 million in the AFP segment, CI segment, and other segments, respectively.

The carrying amounts of intangible assets follow:
 
 
 
 
December 31, 2019
 
December 31, 2018
(Dollars in millions)
Estimated Useful Life in Years
Gross Carrying Value
 
Accumulated Amortization
 
Net Carrying Value
 
Gross Carrying Value
 
Accumulated Amortization
 
Net Carrying Value
Amortizable intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Customer relationships
8
-
25
$
1,566

 
$
494

 
$
1,072

 
$
1,567

 
$
419

 
$
1,148

Technology
7
-
20
677

 
343

 
334

 
680

 
294

 
386

Contracts
 
5


 

 

 
180

 
147

 
33

Other
5
-
37
88

 
22

 
66

 
102

 
23

 
79

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indefinite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tradenames
 
 
 
529

 

 
529

 
529

 

 
529

Other
 
 
 
10

 

 
10

 
10

 

 
10

Total identified intangible assets
 
 
 
$
2,870

 
$
859

 
$
2,011

 
$
3,068

 
$
883

 
$
2,185



Amortization expense of definite-lived intangible assets was $160 million, $164 million, and $164 million for 2019, 2018, and 2017, respectively. Estimated amortization expense for future periods is $130 million in 2020, $125 million in 2021, and $115 million each year for 2022 through 2024.